Pharmaceutical News

RSS

Genzyme begins gene transfer trial for peripheral arterial disease

Genzyme Corporation announced today that the first patient has been treated in a new phase 2 clinical trial examining the safety and effectiveness of locally delivered gene transfer for patients with peripheral arterial disease.

24 Feb 2005

Pfizer acquires Idun Pharmaceuticals

Pfizer today announced that it has entered into an agreement to acquire Idun Pharmaceuticals, a biopharmaceutical company focused on the discovery and development of therapies to control apoptosis, a process of cell death that occurs in a broad range of diseases.

24 Feb 2005

$71 million to launch a new drug

Mid-level pharmaceutical brands invest an average of $71 million in marketing between Phase III trials and the first year on the market, according to a new report from Cutting Edge Information.

24 Feb 2005

FDA approves Atacand (candesartan cilexetil) for the treatment of heart failure

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved its angiotensin receptor blocker (ARB) Atacand (candesartan cilexetil) Tablets for the treatment of heart failure (NYHA class II-IV and ejection fraction less than or equal to 40%) to reduce the risk of death from cardiovascular causes and reduce hospitalizations for heart failure.

23 Feb 2005

Lack of early market research spending lowers drug success rates

Pharmaceutical market research spending during Launch exceeds all market research spending from Pre-Clinical to Phase III, according to a new industry report by Cutting Edge Information. This lack of early market research spending dramatically reduces a product's viability in the competitive marketplace.

23 Feb 2005

Amgen's AMG-162 for treatment of osteoporosis will become a blockbuster by 2013

Decision Resources, Inc., forecasts that Amgen's novel biological agent for the treatment of osteoporosis, AMG-162, will become a blockbuster by 2013. Premium pricing of AMG-162 will propel the sales of this agent.

23 Feb 2005

Taipan venom used as a new drug to treat heart failure

A venom component from the Taipan, the world’s deadliest snake, is being developed by Brisbane biotechnology company ElaCor, as a new drug to treat heart failure.

23 Feb 2005

FDA approval of Vaccinia Immune Globulin to treat adverse reactions to smallpox vaccination

Computer Sciences Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved its Vaccinia Immune Globulin (VIGIV), an intravenous immune globulin, to treat rare adverse reactions to smallpox vaccination.

22 Feb 2005

Pharmaceutical and biotechnology industry in the new EU countries presents considerable potential

In contrast to subdued growth in the pharmaceutical markets of the former 15-state European Union (EU), pharmaceutical markets in the 'new' EU accession markets are expanding vibrantly.

22 Feb 2005

Pharmaceutical companies will be named and shamed for misleading advertising

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) will be naming and shaming companies which engage in misleading advertising of their pharmaceutical products, or which show poor practice in the way they set about their advertising and promotional campaigns.

22 Feb 2005

FDA approves new smallpox vaccination

The U.S. Food and Drug Administration (FDA) has approved Vaccinia Immune Globulin Intravenous (VIGIV) - the first intravenous human plasma-derived product available to treat certain rare complications of smallpox vaccination.

20 Feb 2005

FDA will create a new independent Drug Safety Oversight Board to oversee the management of drug safety issues

In a recent meeting with employees, HHS Secretary Mike Leavitt shared an emboldened vision for the Food and Drug Administration (FDA) that included a new culture of openness, improved oversight and enhanced independence.

16 Feb 2005

Merck issues statement on Vioxx lawsuits

The federal Judicial Panel on Multidistrict Litigation today granted motions by several parties, including Merck, to transfer all Vioxx product liability lawsuits pending in federal courts nationwide into one consolidated Multidistrict Litigation (MDL) for coordinated pre-trial proceedings.

16 Feb 2005

New report detailing how animal experiments misled scientists on Vioxx

Tommorow, February 17, John J. Pippin, M.D., FA.C.C., will testify before Food and Drug Administration (FDA) officials and present a new report detailing how experiments on mice, dogs, and other animals misled scientists and ultimately contributed to a tragic outcome for human patients exposed to Vioxx and other drugs.

15 Feb 2005

Renovis announces investigational medicine for multiple sclerosis study

Renovis announced today the initiation of a Phase Ia clinical trial for REN-850, an investigational oral small molecule that is being targeted for the treatment of multiple sclerosis (MS).

14 Feb 2005

Merck may have known the overuse of mercury in their vaccines posed a dangerous health threat to children

A Los Angeles Times article today reports that Merck, a leading manufacturer of prescription drugs, knew the overuse of mercury in their vaccines posed a dangerous health threat to children.

8 Feb 2005

New advice about the use of Strattera (atomoxetine)

New advice to doctors and patients about the use of Strattera, (atomoxetine), was issued today by the Medicines and Healthcare products Regulatory Agency, (MHRA).

3 Feb 2005

Solbec announces pre-clinical study to confirm findings into the effect of Coramsine combined with CpG in the treatment of murine mesothelioma

Solbec Pharmaceuticals Ltd has announced the commencement of a pre-clinical study to confirm and extend the findings of an earlier investigation into the effect of Coramsine™ combined with CpG in the treatment of murine mesothelioma.

3 Feb 2005

Withdrawal of the commonly prescribed painkiller, co-proxamol

A phased withdrawal of the commonly prescribed painkiller, co-proxamol, has been announced by the Medicines and Healthcare products Regulatory Agency.

1 Feb 2005

Solutions to royalty stacking issues a top priority in pharmaceutical and biotechnology sectors

As new technologies are innovated in the pharmaceutical and biotechnology sectors, the number of fresh patents and related regulations is also on the rise.

31 Jan 2005

Pharmaceutical News

Genzyme begins gene transfer trial for peripheral arterial disease

Pfizer acquires Idun Pharmaceuticals

$71 million to launch a new drug

FDA approves Atacand (candesartan cilexetil) for the treatment of heart failure

Lack of early market research spending lowers drug success rates

Amgen's AMG-162 for treatment of osteoporosis will become a blockbuster by 2013

Taipan venom used as a new drug to treat heart failure

FDA approval of Vaccinia Immune Globulin to treat adverse reactions to smallpox vaccination

Pharmaceutical and biotechnology industry in the new EU countries presents considerable potential

Pharmaceutical companies will be named and shamed for misleading advertising

FDA approves new smallpox vaccination

FDA will create a new independent Drug Safety Oversight Board to oversee the management of drug safety issues

Merck issues statement on Vioxx lawsuits

New report detailing how animal experiments misled scientists on Vioxx

Renovis announces investigational medicine for multiple sclerosis study

Merck may have known the overuse of mercury in their vaccines posed a dangerous health threat to children

New advice about the use of Strattera (atomoxetine)

Solbec announces pre-clinical study to confirm findings into the effect of Coramsine combined with CpG in the treatment of murine mesothelioma

Withdrawal of the commonly prescribed painkiller, co-proxamol

Solutions to royalty stacking issues a top priority in pharmaceutical and biotechnology sectors

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News